Skip to main content
. Author manuscript; available in PMC: 2016 Aug 23.
Published in final edited form as: Circulation. 2016 Feb 23;133(8):742–755. doi: 10.1161/CIRCULATIONAHA.115.008721

Table 3.

The evidence supporting the major resource effective strategies to prevent and treat cardiovascular disease.

Resource Effective Strategies Level of Evidence* References
Tobacco prevention and control policies (WHO MPOWER) A 58-60
Improving price, availability and marketing of healthy foods C 61-65
Simplified CVD-risk screening and management algorithms B 66
Availability of combination therapy for CVD A 12, 67-71
Task-sharing with NPHWs and treatment supporters B 72-78
*

Level-A body of evidence = multiple populations have been evaluated, or data are derived from multiple randomized clinical trials or meta-analyses. A level-B body of evidence = limited populations have been evaluated, or data are derived from a single randomized trial or nonrandomized trial. A level-C body of evidence = very limited populations have been evaluated or that only the consensus opinions of experts, case studies, or standards of care support the recommendation.

WHO=World Health organization, CVD=cardiovascular disease, NPHWs=non-physician health workers